Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2/COVID-19: Viral Genomics, Epidemiology, Vaccines, and Therapeutic Interventions
Mohammed Uddin, Farah Mustafa, Tahir A. Rizvi, et al.
Viruses (2020) Vol. 12, Iss. 5, pp. 526-526
Open Access | Times Cited: 292

Showing 26-50 of 292 citing articles:

SARS-CoV-2 detection and inactivation in water and wastewater: review on analytical methods, limitations and future research recommendations
Parashuram Kallem, Hanaa M. Hegab, Habiba Alsafar, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 23
<p>Saliva as an Alternative Specimen for Molecular COVID-19 Testing in Community Settings and Population-Based Screening</p>
Abiola Senok, Hanan Al Suwaidi, Yusrah Atrah, et al.
Infection and Drug Resistance (2020) Vol. Volume 13, pp. 3393-3399
Open Access | Times Cited: 67
SARS-CoV-2/COVID-19: Viral Genomics, Epidemiology, Vaccines, and Therapeutic Interventions
Mohammed Uddin, Farah Mustafa, Tahir A. Rizvi, et al.
(2020)
Open Access | Times Cited: 57
A review on Promising vaccine development progress for COVID-19 disease
Tafere Mulaw Belete
Vacunas (2020) Vol. 21, Iss. 2, pp. 121-128
Open Access | Times Cited: 50
SEAHIR: A Specialized Compartmental Model for COVID-19
Alexandros Leontitsis, Abiola Senok, Alawi Alsheikh‐Ali, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 5, pp. 2667-2667
Open Access | Times Cited: 45
Molecular optimization, docking, and dynamic simulation profiling of selective aromatic phytochemical ligands in blocking the SARS-CoV-2 S protein attachment to ACE2 receptor: an in silico approach of targeted drug designing
Dipta Dey, Parag Kumar Paul, Salauddin Al Azad, et al.
Journal of Advanced Veterinary and Animal Research (2021) Vol. 8, Iss. 1, pp. 1-1
Open Access | Times Cited: 42
SARS-CoV-2 Nsp8 induces mitophagy by damaging mitochondria
Shan Zong, Yan Wu, Weiling Li, et al.
Virologica Sinica (2023) Vol. 38, Iss. 4, pp. 520-530
Open Access | Times Cited: 16
Antibodies targeting a quaternary site on SARS-CoV-2 spike glycoprotein prevent viral receptor engagement by conformational locking
Lihong Liu, Ryan G. Casner, Yicheng Guo, et al.
Immunity (2023) Vol. 56, Iss. 10, pp. 2442-2455.e8
Open Access | Times Cited: 16
Origin, evolution, and spread of SARS-CoV-2
Jonas Michel Wolf, Lucas Wolf, Paul C. Wolf, et al.
Elsevier eBooks (2025), pp. 5-19
Closed Access
Deciphering the Host-Pathogen Interface in COVID-19: The precision molecular insight into epitranscriptomic modifications of high-impact transcripts
Mateusz Maździarz, Katarzyna Krawczyk, Ewa Lepiarczyk, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Fuzzy-Kognitive Karten angewendet zur Bestimmung des Ansteckungsrisikolevels von SARS-COV-2 basierend auf validiertem Wissen in der wissenschaftlichen Gemeinschaft
Márcio Mendonça, Rodrigo Henrique Cunha Palácios, Ivan Rossato Chrun, et al.
(2025), pp. 191-206
Closed Access
Morus alba L. alleviates influenza viral pneumonia. Evidences of its mechanism of action
Junsong Jing, Yi Sun, Yanna Shui, et al.
Phytomedicine (2025) Vol. 140, pp. 156574-156574
Closed Access
Impact of SARS-CoV-2 variant mutations on susceptibility to monoclonal antibodies and antiviral drugs: a non-systematic review, April 2022 to October 2024
Maja Vukovikj, Angeliki Melidou, Priyanka Nannapaneni, et al.
Eurosurveillance (2025) Vol. 30, Iss. 10
Open Access
COVID-19 Pneumonia in Children: From Etiology to Management
Giuseppe Fabio Parisi, Cristiana Indolfi, Fabio Decimo, et al.
Frontiers in Pediatrics (2020) Vol. 8
Open Access | Times Cited: 48
Data science in unveiling COVID-19 pathogenesis and diagnosis: evolutionary origin to drug repurposing
Jayanta Kumar Das, Giuseppe Tradigo, Pierangelo Veltri, et al.
Briefings in Bioinformatics (2020) Vol. 22, Iss. 2, pp. 855-872
Open Access | Times Cited: 47
Coagulopathy in COVID-19
G. М. Galstyan
PULMONOLOGIYA (2020) Vol. 30, Iss. 5, pp. 645-657
Open Access | Times Cited: 45
Nanotheranostics against COVID-19: From multivalent to immune-targeted materials
Parichehr Hassanzadeh
Journal of Controlled Release (2020) Vol. 328, pp. 112-126
Open Access | Times Cited: 44
The Large Action of Chlorpromazine: Translational and Transdisciplinary Considerations in the Face of COVID-19
Émmanuel Stip, Tahir A. Rizvi, Farah Mustafa, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 44
Comprehensive annotations of the mutational spectra of SARS‐CoV‐2 spike protein: a fast and accurate pipeline
M. Shaminur Rahman, M. Rafiul Islam, M. Nazmul Hoque, et al.
Transboundary and Emerging Diseases (2020) Vol. 68, Iss. 3, pp. 1625-1638
Open Access | Times Cited: 43
Cross-Neutralization Activity Against SARS-CoV-2 is Present in Currently Available Intravenous Immunoglobulins
José María Soberanes Diez, Carolina S. Romero, Júlia Vergara‐Alert, et al.
Immunotherapy (2020) Vol. 12, Iss. 17, pp. 1247-1255
Open Access | Times Cited: 41
Role of eosinophils in the diagnosis and prognostic evaluation of COVID‐19
Yingzheng Tan, Juan Zhou, Qing Zhou, et al.
Journal of Medical Virology (2020) Vol. 93, Iss. 2, pp. 1105-1110
Closed Access | Times Cited: 40
In silico study of some selective phytochemicals against a hypothetical SARS-CoV-2 spike RBD using molecular docking tools
Anish Nag, Subhabrata Paul, Ritesh Banerjee, et al.
Computers in Biology and Medicine (2021) Vol. 137, pp. 104818-104818
Open Access | Times Cited: 39
The SARS-CoV-2 spike protein is vulnerable to moderate electric fields
Claudia R. Arbeitman, Pablo A. Rojas, Pedro Ojeda-May, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 38
Coinfections in Patients Hospitalized with COVID-19: A Descriptive Study from the United Arab Emirates
Abiola Senok, Mubarak Alfaresi, Hamda Khansaheb, et al.
Infection and Drug Resistance (2021) Vol. Volume 14, pp. 2289-2296
Open Access | Times Cited: 38
A Brief Overview of Potential Treatments for Viral Diseases Using Natural Plant Compounds: The Case of SARS-Cov
Rambod Abiri, Hazandy Abdul Hamid, Oksana Sytar, et al.
Molecules (2021) Vol. 26, Iss. 13, pp. 3868-3868
Open Access | Times Cited: 37

Scroll to top